Efficacy and Safety of TACE Combined with Regorafenib Versus TACE Combined with Camrelizumab in Hepatocellular Carcinoma with Untreatable Progression after TACE Combined with Sorafenib Therapy: A Case Control Study.
Cancer Control（2024）
关键词
hepatocellular carcinoma,transarterial chemoembolization,refractory,regorafenib,camrelizumab
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要